Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The University of Cambridge–based DioSynVax and Singapore's ACM Biolabs have signed a deal to jointly develop a ...

The pharmaceutical giant claims that Gutierrez Co. failed to properly design and build its manufacturing facility in Marlborough, Massachusetts.

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.

Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

Q4 2024 Earnings Call Transcript April 10, 2025 CureVac N.V. misses on earnings expectations. Reported EPS is $-0.16564 EPS, ...

The candidate mRNA design applies a unique technology resulting in an in-vivo self-assembly of a protein nanoparticle with clustering of FimH antigen on its surface, which has shown superior ...